We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$169M
Turnover
8.49%
1-Year Est. Return
32.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.43%
1 Year Est. Return
+32.52%
3 Year Est. Return
+106.62%
5 Year Est. Return
+155.24%
10 Year Est. Return
–
AUM
$161M
AUM Growth
-$5.91M
(-3.5%)
Cap. Flow
+$866K
Cap. Flow
% of AUM
0.54%
Top 10 Holdings %
Top 10 Hldgs %
39.37%
Holding
108
New
3
Increased
14
Reduced
43
Closed
6
Avg Time Held
4.5
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
|
+$1.23M |
| 2 |
Exagen
XGN
|
+$1.17M |
| 3 |
Intellicheck
IDN
|
+$1.14M |
| 4 |
Insight Molecular Diagnostics
IMDX
|
+$714K |
| 5 |
Cohu
COHU
|
+$578K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$1.26M |
| 2 |
Comfort Systems
FIX
|
+$1.01M |
| 3 |
INVE Technologies, Inc. Common Stock
INVE
|
+$816K |
| 4 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$296K |
| 5 |
Core Laboratories
CLB
|
+$289K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Healthcare | 20.55% |
| 3 | Financials | 10.66% |
| 4 | Industrials | 9.8% |
| 5 | Consumer Discretionary | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Immersion
IMMR
$231M
| $961K | 0.6% |
140,470
| – | – |
2019 Q1
10 quarters
|
|
52
DELISTED
2U Inc
TWOU
| $956K | 0.59% |
949
| – | – |
2014 Q2
29 quarters
|
|
53
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
| $923K | 0.57% |
6,160
| – | – |
2017 Q4
15 quarters
|
|
54
Berkshire Hathaway Class B
BRK.B
$1.14T
| $921K | 0.57% |
3,375
| – | – |
2013 Q4
31 quarters
|
|
55
Hess Midstream
HESM
$3.94B
| $913K | 0.57% |
32,380
| – | – |
2018 Q2
13 quarters
|
|
56
The ONE Group
STKS
$38.3M
| $889K | 0.55% |
83,205
-11,700
| -12% | -$121K |
2018 Q3
12 quarters
|
|
|
CEMI
57
DELISTED
Chembio diagnostics, Inc.
CEMI
| $887K | 0.55% |
354,670
-600
| -0.2% | -$1.66K |
2019 Q1
10 quarters
|
|
58
DELISTED
Intevac Inc
IVAC
| $884K | 0.55% |
184,900
| – | – |
2020 Q1
6 quarters
|
|
59
Oneok
OKE
$58.8B
| $837K | 0.52% |
14,435
-300
| -2% | -$16.1K |
2015 Q3
24 quarters
|
|
60
Meta Platforms (Facebook)
META
$1.81T
| $815K | 0.51% |
2,400
| – | – |
2014 Q3
28 quarters
|
|
61
Franklin Master Intermediate Income Trust
PIM
$146M
| $802K | 0.5% |
197,152
| – | – |
2013 Q4
31 quarters
|
|
62
Fiserv Inc
FISV
$25.3B
| $791K | 0.49% |
7,291
-550
| -7% | -$61.5K |
2013 Q4
31 quarters
|
|
63
AbbVie
ABBV
$504B
| $783K | 0.49% |
7,262
| – | – |
2014 Q2
29 quarters
|
|
64
Regeneron Pharmaceuticals
REGN
$81.4B
| $770K | 0.48% |
1,272
| – | – |
2021 Q1
2 quarters
|
|
65
Builders FirstSource
BLDR
$5.88B
| $767K | 0.48% |
14,822
-656
| -4% | -$32K |
2021 Q1
2 quarters
|
|
66
iShares Biotechnology ETF
IBB
$10.3B
| $737K | 0.46% |
4,560
-30
| -0.7% | -$5.05K |
2016 Q2
21 quarters
|
|
|
BKI
67
DELISTED
Black Knight, Inc. Common Stock
BKI
| $728K | 0.45% |
10,118
-628
| -6% | -$48.3K |
2017 Q4
15 quarters
|
|
68
Vermilion Energy
VET
$2.02B
| $717K | 0.45% |
72,550
+600
| +0.8% | +$4.39K |
2017 Q4
15 quarters
|
|
69
First American
FAF
$6.63B
| $707K | 0.44% |
10,550
-300
| -3% | -$20K |
2013 Q4
31 quarters
|
|
70
Williams Companies
WMB
$87.2B
| $688K | 0.43% |
26,530
-200
| -0.7% | -$5.04K |
2013 Q4
31 quarters
|
|
71
OptimizeRx
OPRX
$160M
| $613K | 0.38% |
7,166
| – | – |
2021 Q2
1 quarter
|
|
|
RDS.A
72
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $584K | 0.36% |
13,100
| – | – |
2015 Q3
24 quarters
|
|
73
Becton Dickinson
BDX
$52.2B
| $574K | 0.36% |
2,394
| – | – |
2013 Q4
31 quarters
|
|
|
LMRK
74
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
| $569K | 0.35% |
34,830
-1,900
| -5% | -$28.1K |
2015 Q2
25 quarters
|
|
75
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.02B
| $556K | 0.35% |
20,239
-1,000
| -5% | -$27.9K |
2013 Q4
31 quarters
|
|
Similar funds
ACA
CCM
CIA
EG
ANHIM
WS
CBOR
NWMG
Penbrook Management's Q3 2021 Portfolio in Review
As of Q3 2021, Penbrook Management held 108 positions worth $161M, down 3.5% from $167M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Penbrook Management's Q3 2021 filing shows 3 new, 14 increased, 43 reduced and 6 closed positions. Its largest new stake was Atlas Technical Consultants, Inc. Class A Common Stock: 119,395 shares worth $1.21M. The largest sale was Nuance Communications, Inc., an estimated $1.26M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Penbrook Management's largest Q3 2021 buy was Atlas Technical Consultants, Inc. Class A Common Stock: 119,395 shares worth $1.21M.
- Penbrook Management added most to Intellicheck in Q3 2021, an estimated $1.14M increase.
- Penbrook Management's biggest Q3 2021 reduction was Nuance Communications, Inc., cutting an estimated $1.26M.
- Penbrook Management fully exited Comfort Systems in Q3 2021, selling an estimated $1.01M.
- Penbrook Management's ten largest holdings make up 39% of its $161M portfolio in Q3 2021.
- Penbrook Management opened 3 new positions and closed 6 in Q3 2021.
- Penbrook Management's portfolio value fell 3.5% quarter-over-quarter to $161M.
Based on Penbrook Management's 13F filing for Q3 2021, filed 26 Oct 2021.